IMPLANT，用于病态肥胖的胃内植入物
PMA编号：P250023 · 2026-09-23
广告
决定日期2026-09-23
PMA 编号P250023
产品代码LTI
设备分类第3类
医疗专科U
咨询委员会GU
请注意，由于您只提供了“GU”这个词，我无法提供完整的翻译。如果您能提供完整的句子或段落，我将能够为您提供准确的翻译。
器械摘要
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY is the device name listed in this FDA 510(k) record. The listed applicant is Allurion Technologies, Inc.. It received FDA 510(k) clearance on 2026-09-23. The device is classified under product code LTI. It was reviewed by the GU advisory panel.
常见问题
What is the IMPLANT, INTRAGASTRIC FOR MORBID OBESITY?
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY is a medical device that received FDA 510(k) clearance on 2026-09-23. The listed applicant is Allurion Technologies, Inc..
When did IMPLANT, INTRAGASTRIC FOR MORBID OBESITY receive FDA 510(k) clearance?
The clearance date for IMPLANT, INTRAGASTRIC FOR MORBID OBESITY can be found in the official FDA records.
谁是植入式胃内减肥装置的申请人？
The FDA 510(k) record lists Allurion Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY 的 FDA 产品代码是什么？
FDA产品代码为IMPLANT，用于治疗病态肥胖的INTRAGASTRIC，代码为LTI。
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告